Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Considering the Experimental use of Temozolomide in Glioblastoma Research.
Biomedicines. 2020 Jun 4;8(6):151. doi: 10.3390/biomedicines8060151.
Biomedicines. 2020.
PMID: 32512726
Free PMC article.
Review.
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy.
Strobel H, Baisch T, Fitzel R, Schilberg K, Siegelin MD, Karpel-Massler G, Debatin KM, Westhoff MA.
Strobel H, et al. Among authors: baisch t.
Biomedicines. 2019 Sep 9;7(3):69. doi: 10.3390/biomedicines7030069.
Biomedicines. 2019.
PMID: 31505812
Free PMC article.
Review.
Item in Clipboard
Comment in Response to "Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina".
Westhoff MA, Baisch T, Herbener VJ, Karpel-Massler G, Debatin KM, Strobel H.
Westhoff MA, et al. Among authors: baisch t.
Biomedicines. 2020 Apr 20;8(4):93. doi: 10.3390/biomedicines8040093.
Biomedicines. 2020.
PMID: 32326020
Free PMC article.
Item in Clipboard
Negative myoclonus causes locomotory disability in progressive myoclonus epilepsy type EPM1- Unverricht-Lundborg disease.
Vogt H, Baisch T, Mueller-Pfeiffer C, Mothersill IW.
Vogt H, et al. Among authors: baisch t.
Epileptic Disord. 2023 Jun;25(3):297-308. doi: 10.1002/epd2.20017. Epub 2023 May 22.
Epileptic Disord. 2023.
PMID: 37536959
Item in Clipboard
Cite
Cite